Epstein David R insider trades
Epstein David R has filed 52 Form 4s with the SEC that we hold, for Tempus AI, Inc. (TEM) (Director), EVLO (Director), AXLA (Director) and SGEN (CEO, Director), among 7 companies in all. Across all of them we count 6 purchases worth $249.0K and 15 sales worth $2.6M reported on Form 4. In the last 12 months: 3 purchases ($130.8K) and 6 sales ($115.2K). The largest single trade was a sale of 10,620 shares of SGEN worth $2.3M, dated 2023-11-10. The first filing on our record is dated 2021-07-02 and the latest 2026-10-09.
Tempus AI, Inc. (TEM)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2024-12-11 | S, sale reported on Form 4 | 620 | $25.9K | 2024-12-13 |
| 2025-02-03 | S, sale reported on Form 4 | 370 | $19.7K | 2025-02-05 |
| 2025-03-03 | S, sale reported on Form 4 | 250 | $14.4K | 2025-03-05 |
| 2025-03-17 | S, sale reported on Form 4 | 990 | $46.4K | 2025-03-19 |
| 2025-05-01 | S, sale reported on Form 4 | 370 | $19.8K | 2025-05-05 |
| 2025-06-02 | S, sale reported on Form 4 | 250 | $13.8K | 2025-06-04 |
| 2025-08-01 | S, sale reported on Form 4 | 370 | $20.4K | 2025-08-05 |
| 2025-09-02 | S, sale reported on Form 4 | 250 | $18.4K | 2025-09-04 |
| 2025-11-03 | S, sale reported on Form 4 | 370 | $33.3K | 2025-11-05 |
| 2025-12-01 | S, sale reported on Form 4 | 250 | $18.9K | 2025-12-03 |
| 2026-02-02 | S, sale reported on Form 4 | 370 | $22.0K | 2026-02-04 |
| 2026-03-02 | S, sale reported on Form 4 | 250 | $12.7K | 2026-03-04 |
| 2026-06-01 | S, sale reported on Form 4 | 250 | $12.3K | 2026-06-03 |
| 2026-08-03 | S, sale reported on Form 4 | 370 | $16.1K | 2026-08-05 |
EVLO
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-05-27 | P, purchase reported on Form 4 | 17,123 | $25.0K | 2022-05-31 |
AXLA
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-03-16 | P, purchase reported on Form 4 | 26,178 | $50.0K | 2022-03-18 |
SGEN
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2023-11-10 | S, sale reported on Form 4 | 10,620 | $2.3M | 2023-11-13 |
AgomAb Therapeutics NV (AGMB)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2026-10-05 | P, purchase reported on Form 4 | 5,000 | $42.9K | 2026-10-07 |
| 2026-10-06 | P, purchase reported on Form 4 | 5,000 | $43.5K | 2026-10-07 |
| 2026-10-08 | P, purchase reported on Form 4 | 5,000 | $44.5K | 2026-10-09 |
RUBY
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-04-21 | P, purchase reported on Form 4 | 30,000 | $43.2K | 2022-04-22 |
Senti Biosciences Holdings, Inc. (SNTI)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1445826) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms